MINI FUTURE SHORT - MERCK & CO. Share Price

Certificat

DE000MB915P1

Market Closed - Börse Stuttgart 20:38:58 10/05/2024 BST
2.44 EUR 0.00% Intraday chart for MINI FUTURE SHORT - MERCK & CO.
Current month-5.06%
1 month-12.23%
Date Price Change Volume
10/05/24 2.44 0.00% 0
09/05/24 2.44 -3.17% 0
08/05/24 2.52 +2.02% 0
07/05/24 2.47 -8.52% 0
06/05/24 2.7 +0.37% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 08:38 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB915P
ISINDE000MB915P1
Date issued 20/07/2023
Strike 156.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.6
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.38
Lowest since issue 2.18

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus